InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-29 · accession 0001601830-24-000150 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-03 2024-08-29 RXRX Marriott Tina Pres, COO M - OptEx $1.06 +6,000 527.1K +1% +$6,360
D 2024-09-03 2024-08-29 RXRX Marriott Tina Pres, COO S - Sale+OE $7.56 -6,000 521.1K -1% -$45.4K
D 2024-09-03 2024-08-29 RXRX Marriott Tina Pres, COO M - OptEx $0.00 -6,000 464.0K -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-08-29 M A 6,000 $1.06 527,138 D — —
2 Common Class A Common Stock 2024-08-29 S D 6,000 $7.56 521,138 D — — (F2) This transaction was executed in multiple trades at prices ranging from $7.34 to $7.77 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Derivative Stock Option (Right to Buy) 2024-08-29 M D 6,000 $0.00 464,000 D $1.06 · — to 2028-07-22 6,000 Class A Common Stock (F3) Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.